Vumerity Unió Europea - suec - EMA (European Medicines Agency)

vumerity

biogen netherlands b.v. - diroximel fumarate (biib098) - multipel skleros, skovvis förlöpande - immunsuppressiva - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).

Dimethyl fumarate Mylan Unió Europea - suec - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetylfumarat - multipel skleros, skovvis förlöpande - immunsuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Unió Europea - suec - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarat - multipel skleros, skovvis förlöpande - immunsuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Fampridin Medical Valley 10 mg Depottablett Suècia - suec - Läkemedelsverket (Medical Products Agency)

fampridin medical valley 10 mg depottablett

medical valley invest ab - fampridin - depottablett - 10 mg - fampridin 10 mg aktiv substans

Teriflunomide Mylan Unió Europea - suec - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomide - multipel skleros, skovvis förlöpande - immunsuppressiva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Teriflunomide Accord Unió Europea - suec - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomide - multipel skleros, skovvis förlöpande - immunsuppressiva, selektiva immunsuppressiva - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Dimethyl fumarate Sandoz 120 mg Enterokapsel, hård Suècia - suec - Läkemedelsverket (Medical Products Agency)

dimethyl fumarate sandoz 120 mg enterokapsel, hård

sandoz a/s - dimetylfumarat - enterokapsel, hård - 120 mg - propylenglykol hjälpämne; dimetylfumarat 120 mg aktiv substans

Dimethyl fumarate Sandoz 240 mg Enterokapsel, hård Suècia - suec - Läkemedelsverket (Medical Products Agency)

dimethyl fumarate sandoz 240 mg enterokapsel, hård

sandoz a/s - dimetylfumarat - enterokapsel, hård - 240 mg - propylenglykol hjälpämne; dimetylfumarat 240 mg aktiv substans

Teriflunomide Newbury 14 mg Filmdragerad tablett Suècia - suec - Läkemedelsverket (Medical Products Agency)

teriflunomide newbury 14 mg filmdragerad tablett

newbury pharmaceuticals ab - teriflunomid - filmdragerad tablett - 14 mg - laktosmonohydrat hjälpämne; teriflunomid 14 mg aktiv substans

Teriflunomide Sandoz 14 mg Filmdragerad tablett Suècia - suec - Läkemedelsverket (Medical Products Agency)

teriflunomide sandoz 14 mg filmdragerad tablett

sandoz a/s - teriflunomid - filmdragerad tablett - 14 mg - allurarött ac aluminiumlack hjälpämne; laktosmonohydrat hjälpämne; teriflunomid 14 mg aktiv substans; glycerol hjälpämne